CCM
PFE icon

Cinctive Capital Management’s Pfizer PFE Stock Holding History

Cinctive Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-90,000
Closed -$5.32M – 619
2021
Q4 		$5.32M Buy
+90,000
New +$4.46M 0.23% 143

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cinctive Capital Management's PFE Position: Q1 2026 in Review

Cinctive Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 31,828 shares worth $894K. The stake represents 0.06% of the portfolio and ranks #265 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in PFE as recently as Q3 2025.

Cinctive Capital Management first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $15.2M in Q2 2024. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cinctive Capital Management held 31,828 shares of Pfizer worth $894K as of Q1 2026.
  • Pfizer was a new Cinctive Capital Management position in Q1 2026.
  • Pfizer made up 0.06% of Cinctive Capital Management's portfolio in Q1 2026, its #265 holding.
  • Cinctive Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
  • Cinctive Capital Management's Pfizer position peaked at $15.2M in Q2 2024.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.